Expanded collaboration with Nationwide Children's Hospital adds new funding and a third therapeutic candidate (CLN-301) to Alcyone's diversified portfolio of precision CNS therapeutics and delivery ...
Biogen has given Alcyone Therapeutics a starring role in its drug delivery strategy, paying $85 million to buy the biotech and take control of an implant for getting medicines into the spinal canal.
Alcyone Therapeutics hopes to be a standout star and rising goddess in the central nervous system (CNS) treatment landscape. The Massachusetts biotech unveiled itself Wednesday with $23 million in ...
CAMBRIDGE, Mass. and LOWELL, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Alcyone Therapeutics (Alcyone) have entered into a license and collaboration agreement to develop ...
LOWELL — Alcyone Lifesciences Inc., a biotech startup that moved its headquarters to the Boott Mill last summer, said it has entered into an “exclusive clinical collaboration” with Houston-based ...
Alcyone, which has over seven years of experience in digital marketing, has launched a new hyper-local content marketing service for ketamine therapy providers, and other alternative therapy centers.
Biogen and Alcyone Therapeutics (Alcyone) have entered into a collaboration and licensing agreement to develop Alcyone’s ThecaFlex DRx System (ThecaFlex) to improve patient experience and access to ...
LOWELL — Alcyone Lifesciences Inc., a biotech startup that moved its headquarters to the Boott Mill last summer, said it has entered into an “exclusive clinical collaboration” with Houston-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results